ARGOM: Appendix 4 - Guidelines on OTC application for new ...
Information on the regulatory status of the new substance in other countries should be provided. If an application for approval has been rejected or withdrawn prior to approval, or withdrawn (e.g. due to adverse effects) following marketing approval, this should be noted in the application. ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- wc guidelines for new york
- otc medication for eye infection
- fha guidelines on manual underwrite
- otc treatment for eye infection
- cms guidelines on student documentation
- cms guidelines on verbal orders
- otc medication for dry cough
- otc drops for eye infection
- new products on the market for 2017
- cms guidelines on observation billing
- otc treatment for vaginal odor
- otc remedy for conjunctivitis